Flonoltinib
Flonoltinib is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. Flonoltinib has anti-cancer activity[1].
Product Specifications
CAS Number
2387765-27-5
Product Name Alternative
JAK2/FLT3-IN-1
UNSPSC
12352005
Target
Apoptosis; FLT3; JAK
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flonoltinib.html
Concentration
10mM
Purity
99.48
Solubility
DMSO : 35 mg/mL (ultrasonic)
Smiles
OCCN(C1CCN(C2=CC=C(NC3=NC=C(C)C(C4=CN(C(C)C)N=C4)=N3)C=C2F)CC1)C
Molecular Formula
C25H34FN7O
Molecular Weight
467.58
References & Citations
[1]Yang T, et al. Discovery of Potent and Orally Effective Dual JAK2/FLT3 Inhibitors for the Treatment of AcuteMyelogenous Leukemia and Myeloproliferative Neoplasms. J Med Chem. 2019 Oct 31.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
JAK1; JAK2; JAK3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC213634L3 10 µg
RGAG1 (RTL9) (NM_020769) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
C846-500ug 500 µg
Recombinant Human Galectin-3/LGALS3 (C-6His, Human Cells)
Sign In for Pricing
View Details 